Salvianolic Acid A Ameliorates Arsenic Trioxide-Induced Cardiotoxicity Through Decreasing Cardiac Mitochondrial Injury and Promotes Its Anticancer Activity

Arsenic trioxide (ATO) is used as a therapeutic agent in the treatment of acute promyelocytic leukemia (APL). The therapeutic use of arsenic is limited due to its severe cardiovascular side effects. The cardio-protective effect of salvianolic acid A (Sal A) against ATO cardiotoxicity has been report...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing-yi, Wang, Min, Wang, Rui-ying, Sun, Xiao, Du, Yu-yang, Ye, Jing-xue, Sun, Gui-bo, Sun, Xiao-bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954107/
https://www.ncbi.nlm.nih.gov/pubmed/29867492
http://dx.doi.org/10.3389/fphar.2018.00487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954107/
https://www.ncbi.nlm.nih.gov/pubmed/29867492
http://dx.doi.org/10.3389/fphar.2018.00487

Ejemplares similares